PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
Clinical Development Services
Providing comprehensive product development and post-approval services for biopharmaceuticals and devices
- Phase I clinical trial services
- Full service Phase II-IIIb clinical studies for multinational regulatory submissions
- Therapeutic and specialty expertise with dedicated project teams
- Post-approval services, including epidemiology; pharmacoepidemiology and health outcomes; risk management and REMS; safety surveillance studies; real world outcomes studies; medical information; safety; registries; and observational studies
- Clinical data management and information solutions, including consulting and proprietary software tools to speed collection, analysis and reporting of clinical data
Delivering scientific expertise and global resources to ensure successful execution of development programs
- Product development
- Adaptive trial design
- Rare diseases
- Cardiovascular outcomes
- Medical devices
Providing comprehensive lab services that increase speed and precision to accelerate decision making
- Bioanalytical labs
- cGMP labs
- Central labs
- Vaccines and biologics lab
Innovative approaches to improve discovery science
- BioDuro, A PPD® Company
- X-Chem, Inc.
Our commitment to clients and the value we place on quality and delivery are reflected in the honors PPD has earned.
Founded in 1985, PPD has grown from a one-person consulting firm to one of the world's leading contract research organizations (CRO).
Our mission is to help our clients and partners in maximizing returns on their R&D investments.
Our anti-corruption compliance policy and code of conduct provide important guidelines for how we operate our company.
PPD is committed to bringing scientific and clinical expertise, quality and speed to every drug discovery and development program.
PPD’s principal officers provide executive leadership in the day-to-day management of the company.
PPD sees strategic alliances as a logical response to the challenges of drug discovery and development in today's changing health care environment.
Good citizenship and corporate responsibility are at the core of who we are at PPD.
The drug discovery and development process is designed to ensure that only those pharmaceutical products that are both safe and effective are brought to market.
PPD’s board of directors establishes business strategy and provides oversight for company activities.
PPD’s CRO podcast covers the basics about clinical trials and provides information on CROs – how they work and why organizations hire them.
PPD’s commitment to financial and operational excellence is fundamental to its success as a private company.
Please review this information periodically to understand correct usage of information and materials available on this website.
PPD respects the privacy of individuals and complies with internationally recognized standards of privacy protection.